IMAGE: From left to right: Dr. Yan-Ni Shi, Prof. Helge Bode, Janik Kranz, Peter Grün und Andreas Tietze.
Credit: Jürgen Lecher, Goethe University
Many important natural products such as antibiotics, immunosuppressants, or anti-cancer drugs are produced by microorganisms. These natural products are often small peptides, which in several cases are too complex for a chemical synthesis in the laboratory. In the microbial producers of these drugs, the drugs are generated with the help of the NRPS enzymes in a manner similar to a modern automobile factory: at each station, additional parts are added to the basic structure until finally a complete automobile leaves the factory. In the case of NRPS, a specific amino acid is incorporated and processed at each station (module) so that in the end, peptides emerge that can be linear, cyclic or otherwise modified, and which can also carry unusual amino acids.
Although the basic principles of NRPS have been known for a long time, it was previously hardly possible to modify these enzymes in an easy and efficient way that also allows the complete assembly of fully artificial enzymes leading to new-to-nature peptides. While in the past NRPS modification usually led to a dramatic drop in the production titre of the desired modified peptides, the Molecular Biotechnology research group of Professor Helge Bode already published a new method in 2018 that avoided this drawback. The group has now further optimized this method allowing the easy production of new peptides in excellent yield.
“We use fragments of natural NRPS systems from different bacteria as building blocks that we connect to each other using specific assembly points we have identified,” Andreas Tietze and Janik Kranz explain the research approach they developed as part of a larger team in the Bode group. “The yields are comparable to the natural production of the non-modified natural products and the new methods also enable the simple production of peptide libraries, which was not possible before”.
The method is so well established, beginners can use it to produce new peptides after a short training period. But to get to this point was a long way. “Following the first promising experiments by Kenan, my PhD student at the time, we worked for a long time on the project with a major part of my group until we were certain that our method fulfilled the requirements of a robust and easily reproducible engineering method,” Bode states. “Thanks to the LOEWE priority programmes MegaSyn and Translational Biodiversity Genomics, we had the necessary personnel and financial support, and could concentrate completely on the project.”
The next step is to modify the first clinically relevant drugs with this method and produce them in microorganisms applying biotechnology methods. The conditions for this are good – Bode was only recently awarded one of the renowned ERC Advanced Grants from the European Research Council in order to further optimize the methods over the next five years.
Real Life. Real News. Real Voices
Help us tell more of the stories that matter Become a founding member
Kenan A. J. Bozhüyük, Annabell Linck, Andreas Tietze, Janik Kranz, Frank Wesche, Sarah Nowak, Florian Fleischhacker, Yan-Ni Shi, Peter Grün, Helge B. Bode: Modification and de novo design of non-ribosomal peptide synthetases (NRPS) using specific assembly points within condensation domains, Nature Chemistry, https://www.nature.com/articles/s41557-019-0276-z; DOI: https://doi.org/10.1038/s41557-019-0276-z
An image can be downloaded here: http://www.uni-frankfurt.de/78678421
Caption: From left to right: Dr. Yan-Ni Shi, Prof. Helge Bode, Janik Kranz, Peter Grün und Andreas Tietze. Credit: Jürgen Lecher, Goethe-Universität.
Further information: Professor Helge B. Bode, Molecular Biotechnology, Faculty of Biological Sciences, Riedberg Campus, Tel.: +49 69 798-29557, [email protected].
Current news about science, teaching, and society can be found on GOETHE-UNI online (http://www.aktuelles.uni-frankfurt.de)
Goethe University is a research-oriented university in the European financial centre Frankfurt am Main. The university was founded in 1914 through private funding, primarily from Jewish sponsors, and has since produced pioneering achievements in the areas of social sciences, sociology and economics, medicine, quantum physics, brain research, and labour law. It gained a unique level of autonomy on 1 January 2008 by returning to its historic roots as a “foundation university”. Today, it is one of the three largest universities in Germany. Together with the Technical University of Darmstadt and the University of Mainz, it is a partner in the inter-state strategic Rhine-Main University Alliance. Internet: http://www.uni-frankfurt.de
Publisher: The President of Goethe University Editor: Dr. Anne Hardy, Science Editor, PR & Communication Department, Theodor-W.-Adorno-Platz 1, 60323 Frankfurt am Main, Tel: -49 (0) 69 798-13035, Fax: +49 (0) 69 798-763 12531, [email protected]
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe